디네이쳐바이오랩스

본문 바로가기

팝업레이어 알림


352058c20365fb46c6c11493e62a9888_1634620575_21.jpg


    Neurological Disorder-Specialized Cell Therapy Brain Healthcare
    Biotechnology
    Neurological Disorder-Specialized Cell Therapy Brain Healthcare
    Biotechnology
    Neurological Disorder-Specialized Cell Therapy Brain Healthcare
    Biotechnology
    브랜드스토리
    ‘A company that shares its love with people’

    Dnature Bio Labs is striving to grow into an advanced biotech
    R&D company that contributes to humanity and society through its
    brain healthcare business. We are developing leading bio-pharmaceuticals
    for neurodegenerative diseases as well as functional food and beverage
    that help improve neural health.

    • Platform Fetal Neural Stem Cells <DNB100>

      We investigate and develop neural cell therapies for
      Amyotrophic Lateral Sclerosis (Lou Gehrig's disease),
      Stroke, and Alzheimer's disease via isolation &
      cultivation of fetal neural stem/progenitor cells.

      VIEW MORE
    • Pipeline Lou Gehrig's Disease
      Cell Therapy <DNB120>

      As a therapy for Amypotrophic Lateral Sclerosis
      (Lou Gehrig's disease), neural cell therapy is being
      developed under the R&D strategies such as glial cell
      therapy, neuroprotection, neuroregeneration, allogeneic
      cell therapy, off-the shelf, and orphan drug.

      VIEW MORE
    • Pipeline Stroke Cell Therapy <DNB130>

      As a therapy for Stroke, neural cell therapy is
      being developed under R&D strategies such as neural
      cell therapy, neuroprotection, neuroregeneration,
      allogeneic cell therapy, off-the shelf, and expansion
      into another indication.

      VIEW MORE
    MEDIA
    PRESS
    NOTICE
    No. TITLE DATE